Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Oncoimmunology|October 10, 2022
Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodiesRebecca Adams, Gabriel Osborn, Bipashna Mukhia, et al.
Oncoimmunology|August 1, 2022
Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ TregsRobert J Harris, Zena Willsmore, Roman Laddach, et al.
Expert Review of Clinical Immunology|February 23, 2022
BRAF inhibitors and their immunological effects in malignant melanomaRebecca Adams, Jack E M Coumbe, Ben G T Coumbe, et al.
Plos One|May 12, 2011
Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodiesAmy E Gilbert, Panagiotis Karagiannis, Tihomir Dodev, et al.
Scientific Reports|July 15, 2016
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinLouise Saul, Kristina M Ilieva, Heather J Bax, et al.
The Journal of Clinical Investigation|March 5, 2013
IgG4 subclass antibodies impair antitumor immunity in melanomaPanagiotis Karagiannis, Amy E Gilbert, Debra H Josephs, et al.
Frontiers in Immunology|February 11, 2021
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor AntibodiesZena N Willsmore, Robert J Harris, Silvia Crescioli, et al.
European Journal of Immunology|January 15, 2021
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of actionZena N Willsmore, Ben G T Coumbe, Silvia Crescioli, et al.
Frontiers in Immunology|April 4, 2019
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in MelanomaDuaa O Khair, Heather J Bax, Silvia Mele, et al.
Nature Communications|May 15, 2023
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4Jitesh Chauhan, Melanie Grandits, Lais C G F Palhares, et al.
Pageof 3